HUP9900887A3 - Novel nor-pregnanes for inducing hypothalamic effects, thear production and medicaments containing them - Google Patents
Novel nor-pregnanes for inducing hypothalamic effects, thear production and medicaments containing themInfo
- Publication number
- HUP9900887A3 HUP9900887A3 HU9900887A HUP9900887A HUP9900887A3 HU P9900887 A3 HUP9900887 A3 HU P9900887A3 HU 9900887 A HU9900887 A HU 9900887A HU P9900887 A HUP9900887 A HU P9900887A HU P9900887 A3 HUP9900887 A3 HU P9900887A3
- Authority
- HU
- Hungary
- Prior art keywords
- thear
- pregnanes
- novel
- production
- medicaments containing
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 230000002267 hypothalamic effect Effects 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/485,615 US5792757A (en) | 1994-08-04 | 1995-06-07 | 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9900887A2 HUP9900887A2 (hu) | 1999-08-30 |
| HUP9900887A3 true HUP9900887A3 (en) | 1999-11-29 |
Family
ID=23928825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9900887A HUP9900887A3 (en) | 1995-06-07 | 1996-06-07 | Novel nor-pregnanes for inducing hypothalamic effects, thear production and medicaments containing them |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US5792757A (hu) |
| EP (1) | EP0830369B1 (hu) |
| JP (1) | JPH11507360A (hu) |
| KR (1) | KR19990022640A (hu) |
| CN (1) | CN1191542A (hu) |
| AT (1) | ATE240344T1 (hu) |
| AU (1) | AU724787B2 (hu) |
| BR (1) | BR9609012A (hu) |
| CA (1) | CA2223397C (hu) |
| CZ (1) | CZ391597A3 (hu) |
| DE (1) | DE69628163T2 (hu) |
| EA (1) | EA000965B1 (hu) |
| ES (1) | ES2197949T3 (hu) |
| HU (1) | HUP9900887A3 (hu) |
| NO (1) | NO975709L (hu) |
| NZ (1) | NZ312303A (hu) |
| WO (1) | WO1996040727A1 (hu) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6331534B1 (en) | 1994-08-04 | 2001-12-18 | Pherin Pharmaceuticals, Inc. | Steroids as neurochemical stimulators of the VNO to alleviate pain |
| US6057439A (en) * | 1994-08-04 | 2000-05-02 | Pherin Corporation | Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety |
| US6117860A (en) * | 1994-08-04 | 2000-09-12 | Pherin Pharmaceuticals, Inc. | Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia |
| US6066627A (en) * | 1994-08-04 | 2000-05-23 | Pherin Corporation | Steroids as neurochemical initiators of change in human blood levels of LH |
| US5922699A (en) * | 1996-06-07 | 1999-07-13 | Pherin Corporation | 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| AU726625B2 (en) * | 1996-07-23 | 2000-11-16 | Pherin Pharmaceuticals, Inc. | Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety |
| EP1079859B1 (en) | 1998-05-22 | 2010-07-14 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
| EP1228083A2 (en) | 1999-09-30 | 2002-08-07 | Hollis-Eden Pharmaceuticals Inc. | Therapeutic treatment of androgen receptor driven conditions |
| AUPQ342599A0 (en) * | 1999-10-14 | 1999-11-04 | University Of Melbourne, The | Conjugates and uses thereof |
| US6555531B1 (en) * | 1999-12-30 | 2003-04-29 | Pherin Pharmaceuticals, Inc. | Weight promoting composition, method, and product |
| US6413951B2 (en) * | 2000-06-27 | 2002-07-02 | Aventis Pharmaceuticals, Inc. | 20-fluoro-17(20)-vinyl steroids |
| AU2002244247B2 (en) | 2001-03-01 | 2007-12-13 | Harbor Biosciences, Inc. | Use of certain steroids for treatment of blood cell deficiencies |
| JP4202250B2 (ja) | 2001-07-25 | 2008-12-24 | バイオマリン ファーマシューティカル インコーポレイテッド | 血液脳関門輸送を調節するための組成物および方法 |
| CA2496867A1 (en) | 2002-08-28 | 2004-03-11 | Hollis-Eden Pharmaceuticals, Inc. | Therapeutic treatment methods |
| CA2582231A1 (en) | 2004-09-29 | 2006-10-19 | Hollis-Eden Pharmaceuticals, Inc. | Steroid analogs and uses |
| CA2789262C (en) | 2005-04-28 | 2016-10-04 | Proteus Digital Health, Inc. | Pharma-informatics system |
| WO2007035716A2 (en) | 2005-09-16 | 2007-03-29 | Raptor Pharmaceutical Inc. | Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof |
| US20090075964A1 (en) * | 2007-09-17 | 2009-03-19 | Human Pheromone Sciences, Inc. | Fragrance compositions and other compositions which contain naturally occurring substances found in corals |
| JP5524177B2 (ja) | 2008-04-09 | 2014-06-18 | フェリン ファーマシューティカルズ インコーポレイテッド | ほてりのためのステロイド治療 |
| ES2919563T3 (es) | 2009-02-20 | 2022-07-27 | Enhanx Biopharm Inc | Sistema de administración de medicamentos a base de glutatión |
| CN110075069A (zh) | 2009-05-06 | 2019-08-02 | 实验室护肤股份有限公司 | 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其应用 |
| KR102614507B1 (ko) * | 2013-04-17 | 2023-12-19 | 세이지 테라퓨틱스, 인크. | 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법 |
| EP3194417B1 (en) * | 2014-09-17 | 2020-10-28 | Prevacus, Inc. | Ent-19-norprogesterone for use in the treatment of traumatic brain injury |
| DE102020204509A1 (de) | 2020-04-07 | 2021-10-07 | Henkel Ag & Co. Kgaa | Waschmittel mit Pheromonen |
| DE102020204506A1 (de) | 2020-04-07 | 2021-10-07 | Henkel Ag & Co. Kgaa | Weichspüler mit Pheromonen |
| DE102020204507A1 (de) | 2020-04-07 | 2021-10-07 | Henkel Ag & Co. Kgaa | Weichspüler mit aphrodisierend wirkenden Duftstoffen |
| DE102020204505A1 (de) | 2020-04-07 | 2021-10-07 | Henkel Ag & Co. Kgaa | Wasch-/Pflegeartikel umfassend Pheromone |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL287863A (hu) | ||||
| US2840582A (en) * | 1953-08-31 | 1958-06-24 | Searle & Co | Derivatives of 13-methyl-17-hydroxy-1, 2, 3, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 17-tetradecahydro-15h-cyclopenta[a]phenanthren-3-ones |
| DE1297603B (de) | 1964-08-08 | 1969-06-19 | Schering Ag | Verfahren zur Herstellung von 3-Keto-delta 17(20)-pregnenen |
| ES319318A1 (es) | 1964-11-13 | 1966-10-16 | American Cyanamid Co | Procedimiento para la preparaciën de una composiciën anticonceptiva |
| US3385849A (en) * | 1965-07-01 | 1968-05-28 | Hoffmann La Roche | Process for the preparation of 17beta-pregnanes from 17-oxo-steroids |
| US3492318A (en) * | 1968-01-22 | 1970-01-27 | Syntex Corp | Cyclopropenyl androstanes |
| US3682983A (en) * | 1969-11-12 | 1972-08-08 | Klaus Prezewowsky | Preparation of {66 {11 {11 -17 ethinyl steroids |
| FR2097045A1 (en) | 1970-07-30 | 1972-03-03 | Roussel Uclaf | 17-ethynylgon-4-en-3-ones - with progestomimetic activity useful as contraceptives and for gynaecological disorders |
| US3681410A (en) * | 1970-08-07 | 1972-08-01 | Syntex Corp | Process for preparing 17{60 -hydroxy-20-keto and 17{60 ,21-dihydroxy-20-keto pregnanes and derivatives and intermediates thereof |
| US3946052A (en) * | 1975-06-16 | 1976-03-23 | Stanford Research Institute | 19-Norpregna- 1,3,5(10)-trien-3-ol and loweralkyl homologs thereof having postcoital antifertility activity |
| US5155045A (en) | 1985-01-25 | 1992-10-13 | Trustees Of The University Of Penn. | Use of male essence to alter female endocrine response |
| US5108995A (en) | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
| JP2578369B2 (ja) * | 1989-05-09 | 1997-02-05 | ポーラ化成工業株式会社 | 芳香組成物 |
| GB8912043D0 (en) * | 1989-05-25 | 1989-07-12 | Beecham Group Plc | Novel compounds |
| US5272134A (en) * | 1992-03-24 | 1993-12-21 | Erox Corporation | Fragrance compositions and other compositions which contain human pheromones |
| US5278141A (en) * | 1992-03-24 | 1994-01-11 | Erox Corporation | Fragrance compositions containing human pheromones |
-
1995
- 1995-06-07 US US08/485,615 patent/US5792757A/en not_active Expired - Lifetime
-
1996
- 1996-06-07 AU AU63807/96A patent/AU724787B2/en not_active Ceased
- 1996-06-07 AT AT96923241T patent/ATE240344T1/de not_active IP Right Cessation
- 1996-06-07 KR KR1019970709215A patent/KR19990022640A/ko not_active Ceased
- 1996-06-07 BR BR9609012-0A patent/BR9609012A/pt unknown
- 1996-06-07 CZ CZ973915A patent/CZ391597A3/cs unknown
- 1996-06-07 JP JP9501937A patent/JPH11507360A/ja active Pending
- 1996-06-07 CA CA002223397A patent/CA2223397C/en not_active Expired - Fee Related
- 1996-06-07 US US08/660,297 patent/US5962443A/en not_active Expired - Lifetime
- 1996-06-07 ES ES96923241T patent/ES2197949T3/es not_active Expired - Lifetime
- 1996-06-07 EP EP96923241A patent/EP0830369B1/en not_active Expired - Lifetime
- 1996-06-07 EA EA199800052A patent/EA000965B1/ru not_active IP Right Cessation
- 1996-06-07 CN CN96195782A patent/CN1191542A/zh active Pending
- 1996-06-07 WO PCT/US1996/009665 patent/WO1996040727A1/en not_active Ceased
- 1996-06-07 NZ NZ312303A patent/NZ312303A/xx unknown
- 1996-06-07 HU HU9900887A patent/HUP9900887A3/hu unknown
- 1996-06-07 DE DE69628163T patent/DE69628163T2/de not_active Expired - Lifetime
-
1997
- 1997-12-05 NO NO975709A patent/NO975709L/no not_active Application Discontinuation
-
1998
- 1998-08-11 US US09/131,998 patent/US6242619B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO975709L (no) | 1998-02-05 |
| EA199800052A1 (ru) | 1998-08-27 |
| DE69628163T2 (de) | 2004-04-01 |
| US5792757A (en) | 1998-08-11 |
| CZ391597A3 (cs) | 1998-06-17 |
| BR9609012A (pt) | 1999-12-14 |
| WO1996040727A1 (en) | 1996-12-19 |
| CA2223397A1 (en) | 1996-12-19 |
| KR19990022640A (ko) | 1999-03-25 |
| MX9709693A (es) | 1998-10-31 |
| JPH11507360A (ja) | 1999-06-29 |
| EP0830369B1 (en) | 2003-05-14 |
| CN1191542A (zh) | 1998-08-26 |
| NO975709D0 (no) | 1997-12-05 |
| AU6380796A (en) | 1996-12-30 |
| NZ312303A (en) | 2000-01-28 |
| AU724787B2 (en) | 2000-09-28 |
| CA2223397C (en) | 2007-07-31 |
| EP0830369A4 (en) | 1999-06-09 |
| ES2197949T3 (es) | 2004-01-16 |
| ATE240344T1 (de) | 2003-05-15 |
| EA000965B1 (ru) | 2000-08-28 |
| US5962443A (en) | 1999-10-05 |
| EP0830369A1 (en) | 1998-03-25 |
| US6242619B1 (en) | 2001-06-05 |
| DE69628163D1 (de) | 2003-06-18 |
| HUP9900887A2 (hu) | 1999-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9900887A3 (en) | Novel nor-pregnanes for inducing hypothalamic effects, thear production and medicaments containing them | |
| PL327445A1 (en) | Novel process | |
| GB9503382D0 (en) | Process | |
| GB9500675D0 (en) | Process | |
| GB9503385D0 (en) | Process | |
| GB9523387D0 (en) | Production process | |
| GB9510126D0 (en) | Novel process | |
| GB9503383D0 (en) | Process | |
| EP0876352A4 (en) | METHOD | |
| GB9500977D0 (en) | Novel process | |
| ZA967421B (en) | Novel process | |
| GB9622136D0 (en) | Extraction process | |
| GB9504708D0 (en) | Process | |
| HU9701137D0 (en) | Process for producing pharmaceutical intermedier | |
| GB2304713B (en) | Novel process | |
| GB2299809B (en) | Process | |
| GB9614562D0 (en) | Novel process | |
| GB9504060D0 (en) | Novel process | |
| GB9504078D0 (en) | Novel process | |
| GB9510644D0 (en) | Pharmaceutical process | |
| GB9402589D0 (en) | Pharmaceutical process | |
| GB9511927D0 (en) | Novel therapeutic method | |
| GB9511354D0 (en) | Novel therapeutic method | |
| GB9510671D0 (en) | Novel therapeutic method | |
| GB9518405D0 (en) | Novel process |